Eric Venker

CIK 1801917 · President & Immunovant CEO · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$56.92M

Companies

3

Total Filings

83

Lifetime Open-Market Net

-$180.01M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ROIV President & Immunovant CEO 1,613,063 $30.04 $48.46M -$156.30M 48 2026-05-22
IMVT Chief Executive Officer 251,813 $33.62 $8.47M -$342.9K 3 2026-04-09
Roivant Sciences Ltd. (ROIVW) Delisted President & COO 611,813 $2.75 $1.68M -$23.37M 32 2023-08-24

Recent Filings · Page 3 of 9

83 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-06-24 ROIV Mixed -$760.0K EDGAR
2025-06-04 ROIV Mixed +385,026 -$5.82M EDGAR
2025-05-22 ROIV Mixed −39,148 -$1.14M EDGAR
2025-04-22 ROIV Mixed −10,945 -$748.1K EDGAR
2025-03-24 ROIV Mixed +241,366 -$4.45M EDGAR
2025-02-24 ROIV Mixed −10,945 -$797.3K EDGAR
2025-02-14 ROIV Mixed +164,575 -$2.25M EDGAR
2025-01-22 ROIV Mixed −8,682 -$839.8K EDGAR
2024-12-31 ROIV Mixed +145,396 -$2.22M EDGAR
2024-12-26 ROIV Mixed −10,945 -$890.6K EDGAR
Showing 2130 of 83
Page 3 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.